Last Updated on February 9, 2021 by The Health Master
“This was a scheduled inspection and at the end of the inspection, the USFDA issued a Form 483 with five observations,” informed a company statement.
A Form 483 is issued to a company after concluding an inspection when an investigator has observed any conditions that in its judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
Alembic Pharma informed that “none of the observations are related to data integrity and are procedural in nature.”
“The company is preparing the response to the observations, which will be submitted to USFDA shortly,” it said.
Go to main website, click here
Subscribe for daily free updates, click here
For daily free updates on WhatsApp, click here